NL237293A - - Google Patents
Info
- Publication number
- NL237293A NL237293A NL237293DA NL237293A NL 237293 A NL237293 A NL 237293A NL 237293D A NL237293D A NL 237293DA NL 237293 A NL237293 A NL 237293A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79329259A | 1959-02-16 | 1959-02-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL237293A true NL237293A (tr) |
Family
ID=25159582
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL100550D NL100550C (tr) | 1959-02-16 | ||
| NL237293D NL237293A (tr) | 1959-02-16 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL100550D NL100550C (tr) | 1959-02-16 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US3704295A (tr) |
| DE (1) | DE1152101B (tr) |
| NL (2) | NL237293A (tr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
| DE2727367A1 (de) * | 1977-06-14 | 1979-01-04 | Schering Ag | Neue kortikoide |
| US4356175A (en) * | 1978-10-10 | 1982-10-26 | The Upjohn Company | 17β-Hydroxy-17α-methyl-5α-androstano-[3,2-c]pyrazole 17-methyl ether |
| US4585765A (en) * | 1978-10-10 | 1986-04-29 | The Upjohn Company | 17β-hydroxy-17α-methyl-5α-androstano[3,2-c]pyrazole 17-methyl ether |
| US4269831A (en) * | 1979-05-09 | 1981-05-26 | Sterling Drug Inc. | Topical dermatological method of use of an androstenopyrazole |
| US4252798A (en) * | 1980-02-14 | 1981-02-24 | The Upjohn Company | Reversible male contraception |
| US4684636A (en) * | 1985-06-24 | 1987-08-04 | Sterling Drug Inc. | Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof |
| DE4021433A1 (de) * | 1990-07-04 | 1992-01-09 | Schering Ag | Antiandrogene mit steroid(3,2-c)pyrazol-struktur |
| KR20100087147A (ko) * | 2007-10-04 | 2010-08-03 | 아스트라제네카 아베 | 글루코코르티코이드 활성을 갖는 스테로이드성 [3,2-ｃ]피라졸 화합물 |
-
0
- NL NL100550D patent/NL100550C/xx active
- NL NL237293D patent/NL237293A/xx unknown
-
1959
- 1959-02-16 US US793292A patent/US3704295A/en not_active Expired - Lifetime
- 1959-03-23 DE DEST14920A patent/DE1152101B/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US3704295A (en) | 1972-11-28 |
| NL100550C (tr) | |
| DE1152101B (de) | 1963-08-01 |